• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[静脉注射免疫球蛋白对血液透析患者免疫系统的支持作用]

[Support to the immune system by Venoglobulin I in hemodialized patients].

作者信息

Isai H, Sato K, Kasai Y, Kawamura A, Nakao A

出版信息

Hokkaido Igaku Zasshi. 1983 Jan;58(1):74-8.

PMID:6188672
Abstract

With the advance of hemodialysis, it has become apparent that immunity, especially cellular, is lowered in patients on maintenance hemodialysis. We administered Venoglobulin I (VGI) to the patients on maintenance hemodialysis to study the change in the immune system and the episodes of infection. VGI was administered to twelve cases, eight males and four females, and their mean period of hemodialysis was three years. Administration of VGI started in February 1981 an mean duration of administration was 7.8 months. As a rule, 2.5g of VGI was administered every 20 days. Counts of white blood cells, lymphocytes, T cells and B cells were measured every two months. The cases were divided into two groups according to the duration of hemodialysis: Group A, less than a year and Group B, more than a year and a month. Results and conclusions 1) VGI increases the lymphocytes and T cell counts in Group B to suggest the improvement of cellular immunity. 2) In Group A, lymphocytes and T cell counts were decreased because the effects of VGI were overcome by the effect of hemodialysis to distort the immune system. 3) The magnitude of effects of VGI was proportional to the period of administration. The effect appeared at least within eight months, and once it appeared, it kept stable level. 4) There had been no episodes of infection during the period of study. 5) With these results, it was indicated that administration of VGI to the patients on maintenance hemodialysis was useful because VGI could support their lowered cellular immunity to some extent.

摘要

随着血液透析技术的进步,维持性血液透析患者免疫力降低,尤其是细胞免疫功能降低已变得很明显。我们对维持性血液透析患者给予静脉注射免疫球蛋白(VGI),以研究免疫系统的变化及感染发作情况。对12例患者给予VGI,其中男性8例,女性4例,他们的平均血液透析时间为3年。VGI给药始于1981年2月,平均给药持续时间为7.8个月。通常每20天给予2.5g VGI。每两个月检测白细胞、淋巴细胞、T细胞和B细胞计数。根据血液透析时间将病例分为两组:A组,透析时间少于1年;B组,透析时间超过1年零1个月。结果与结论:1)VGI使B组淋巴细胞和T细胞计数增加,提示细胞免疫功能改善。2)在A组,淋巴细胞和T细胞计数减少,因为血液透析的作用抵消了VGI的作用,从而扭曲了免疫系统。3)VGI的作用强度与给药时间成正比。至少在8个月内出现作用,一旦出现,便保持稳定水平。4)研究期间未发生感染发作。5)基于这些结果表明,对维持性血液透析患者给予VGI是有益的,因为VGI能在一定程度上支持其降低的细胞免疫功能。

相似文献

1
[Support to the immune system by Venoglobulin I in hemodialized patients].[静脉注射免疫球蛋白对血液透析患者免疫系统的支持作用]
Hokkaido Igaku Zasshi. 1983 Jan;58(1):74-8.
2
NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).4,4'-硫代双(6-叔丁基间甲酚)(CAS编号:96-69-5)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学和致癌性研究(饲料研究)
Natl Toxicol Program Tech Rep Ser. 1994 Dec;435:1-288.
3
Urinary infection in patients with chronic renal failure on hemodialysis.接受血液透析的慢性肾衰竭患者的尿路感染
Med Interne. 1987 Jul-Sep;25(3):195-203.
4
NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).香豆素(CAS编号91-64-5)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学和致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 1993 Sep;422:1-340.
5
NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies).氧甲氢龙(CAS编号:434-07-1)在F344/N大鼠中的NTP毒理学与致癌性研究以及氧甲氢龙在B6C3F1小鼠中的毒理学研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 1999 Aug;485:1-233.
6
[Immune response in the early period after open-heart surgery and the effect of human immune globulin].[心脏直视手术后早期的免疫反应及人免疫球蛋白的作用]
Rinsho Kyobu Geka. 1984 Nov;4(6):713-7.
7
Determinants of soluble CD23 antigen levels in hemodialysis patients: effect of 1.25 dihydroxyvitamin D3 and recombinant human erythropoietin treatment.血液透析患者可溶性CD23抗原水平的决定因素:1,25-二羟维生素D3和重组人促红细胞生成素治疗的影响。
Clin Nephrol. 1999 Oct;52(4):230-8.
8
[Tuberculosis in compromised hosts].[免疫功能低下宿主中的结核病]
Kekkaku. 2003 Nov;78(11):717-22.
9
NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).NTP关于茶碱(CAS编号58-55-9)在F344/N大鼠和B6C3F1小鼠中的毒理学和致癌性研究(饲料和灌胃研究)
Natl Toxicol Program Tech Rep Ser. 1998 Aug;473:1-326.
10
NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).1-氨基-2,4-二溴蒽醌(CAS编号:81-49-2)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学与致癌性研究(饲料喂养研究)
Natl Toxicol Program Tech Rep Ser. 1996 Aug;383:1-370.